739
Participants
Start Date
June 30, 2004
Primary Completion Date
October 31, 2006
Study Completion Date
November 30, 2006
clevidipine
sodium nitroprusside
Hospital of the University of Pennsylvania, Philadelphia
St. Joseph Medical Center, Towson
Virginia Commonwealth University Medical Center, Richmond
Shands Hospital at the University of Florida, Gainesville
Health First Holmes Regional Medical Center, Melbourne
Saint Vincents Hospital, Birmingham
Brookwood Medical Center, Birmingham
Baptist Medical Center, Montclair, Birmingham
Baptist Medical Center, South, Montgomery
Drug Research and Analysis Corporation, Montgomery
Jackson-Madison County General Hospital, Jackson
The Christ Hospital, Cincinnati
Henry Ford Health System, Detroit
Medical College of Wisconsin VAMC - Milwaukee, Milwaukee
Saint Lukes Hospital, Duluth
International Heart Institute/St. Patrick Hospital, Missoula
St. Francis Hospital of Evanston, Evanston
St. Francis Hospital and Health Center, Blue Island
Wesley Medical Center, Wichita
Touro Infirmary, New Orleans
Ochsner Clinic Foundation, New Orleans
Houston Northwest Medical Center, Houston
LDS Hospital, Salt Lake City
Providence Saint Joseph Medical Center, Burbank
Stanford University Medical Center, Stanford
Kaiser Permanente, Honolulu
Portland VA Medical Center, Portland
Massachussettes General Hospital, Boston
Mt. Sinai Medical Center, New York
Lead Sponsor
The Medicines Company
INDUSTRY